Novel Therapy Approaches to Follicular Lymphoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical)
Link
http://link.springer.com/content/pdf/10.1007/s40265-020-01446-1.pdf
Reference148 articles.
1. Cancer Stat Facts: NHL—Follicular Lymphoma [Internet]. https://seer.cancer.gov/statfacts/html/follicular.html. Accessed 30 Oct 2020
2. Smith A, Crouch S, Lax S, Li J, Painter D, Howell D, et al. Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network. Br J Cancer. 2015;112:1575–84.
3. Batlevi CL, Sha F, Alperovich A, Ni A, Smith K, Ying Z, et al. Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups. Blood Cancer J. 2020;10:74.
4. Tarella C, Gueli A, Delaini F, Barbui AM, Bruna R, Caracciolo D, et al. Life expectancy in follicular lymphoma is mainly determined by response to first line treatment: a long-term survey on 597 patients. Blood. 2015;126:3989–3989.
5. Sarkozy C, Maurer MJ, Link BK, Ghesquieres H, Nicolas E, Thompson CA, et al. Cause of death in follicular lymphoma in the first decade of the rituximab era: a pooled analysis of French and US Cohorts. J Clin Oncol. 2019;37:144–52.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mosunetuzumab for the treatment of follicular lymphoma;Expert Opinion on Biological Therapy;2024-09-11
2. Targeting the epigenome to reinvigorate T cells for cancer immunotherapy;Military Medical Research;2023-12-04
3. Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China;Frontiers in Oncology;2022-09-16
4. CAR T-Cell Therapy in the Older Person: Indications and Risks;Current Oncology Reports;2022-04-14
5. Downregulation of MEG3 and upregulation of EZH2 cooperatively promote neuroblastoma progression;Journal of Cellular and Molecular Medicine;2022-03-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3